In addition, cAMP can induce diffuse large B-cell lymphoma cell apoptosis by inhibiting spleen tyrosine kinase (SYK)/PI3K/AKT pathway, which is independent of PKA and EPAC [96]. Here, RAPGEF3 is linked to diffuse large B-cell lymphoma.